APO-Bortezomib bortezomib 3.5mg powder for injection vial

Quốc gia: Úc

Ngôn ngữ: Tiếng Anh

Nguồn: Department of Health (Therapeutic Goods Administration)

Thành phần hoạt chất:

bortezomib, Quantity: 3.5 mg

Sẵn có từ:

Arrotex Pharmaceuticals Pty Ltd

INN (Tên quốc tế):

Bortezomib

Dạng dược phẩm:

Injection, powder for

Thành phần:

Excipient Ingredients: mannitol

Tuyến hành chính:

Subcutaneous, Intravenous

Các đơn vị trong gói:

1

Loại thuốc theo toa:

(S4) Prescription Only Medicine

Chỉ dẫn điều trị:

Bortezomib, in combination with melphalan and prednisone is indicated for the treatment of patients with previously untreated multiple myeloma who are not candidates for high dose chemotherapy.,Bortezomib, as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma.,Bortezomib is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy and who have progressive disease.

Tóm tắt sản phẩm:

Visual Identification: White to off-white powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Tình trạng ủy quyền:

Licence status A

Ngày ủy quyền:

2015-07-22